Skip to content

Drug interactions

Eliglustat + Sunitinib

Severity: Moderate

Eliglustat and Sunitinib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Both sunitinib and eliglustat can lengthen the QT interval, and eliglustat at high concentrations prolongs PR, QRS and QT intervals. Together they may increase the likelihood of ventricular arrhythmias, particularly in patients with cardiac disease or electrolyte imbalance.

What this interaction means in plain words

Eliglustat and Sunitinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Eliglustat belongs to Miscellaneous; Sunitinib belongs to Oncology.

Evidence level: Moderate

Why it happens

Additive pharmacodynamic prolongation of cardiac repolarization.

What to do

Check a baseline ECG and monitor QTc during co-therapy, correcting potassium and magnesium. Avoid in patients with congenital long QT or significant heart disease where possible.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Eliglustat and Sunitinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Eliglustat with Sunitinib?

MediHelp rates the interaction as moderate. Eliglustat and Sunitinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Both sunitinib and eliglustat can lengthen the QT interval, and eliglustat at high concentrations prolongs PR, QRS and QT intervals. Together they may increase the likelihood of ventricular arrhythmias, particularly in patients with cardiac disease or electrolyte imbalance.

How serious is the interaction between Eliglustat and Sunitinib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Check a baseline ECG and monitor QTc during co-therapy, correcting potassium and magnesium. Avoid in patients with congenital long QT or significant heart disease where possible.

What other medicines interact with Sunitinib?

MediHelp also lists interactions of Sunitinib with, for example, Adagrasib, Amiodarone, Amisulpride. The full list is on the Sunitinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in